View Author
Dechering, K.J.
(Koen Dechering)
expression cancer oestrogen gene expression breast formation bone formation donor zr -75-1 cells growth bcar 1 breast cancer receptor vivo bone formation microarray -75-1 medium tissue treatment marker culture cadm 1 change bone-forming bone tissue engineering proliferation capacity differentiation osteogenic factor correlation analysis mesenchymal level marrow protein model classi classi fier bone-forming capacity bcar 3 result r /bcs medium sample experiment dorsser identi fied engineering breast cancer cells effect table profile netherland expansion foekens ja stromal target van blitterswijk c ectopic bone formation label zr /egfr cells resistance comparison boer j ef ficacy zr -75-1 status van blitterswijk curve calcium knockout dorssers lcj van agthoven tla e 2 7 7 days epidermal blitterswijk cadm 1 expression vivo bone-forming capacity expression profiles
2 Most Recent Publications
|
Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1
(Article)
Mentink, A.A. Hulsman, M. Blitterswijk, C.A. van Boer, J. de Groen, N. Licht, R. Dechering, K.J. Stok, J. van der Alves, H. Dhert, W.J.A. Someren, E.P. van Reinders, M.J.T. |
2013-06-01
|
|
Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
(Article)
Dorssers, L.C.J. Brinkman, A. Veldscholte, J. Smid, M. Dechering, K.J. Agthoven, A.J. van |
2005-01-01
|
